PTPN9 and non-small cell lung carcinoma: In the same way, BMSC-derived EVs carrying miR-126-3p suppressed the viability, migration, and invasion of NSCLC cells by targeting protein tyrosine phosphatase non-receptor type 9 (PTPN9) [153].